News

Read the latest news and updates from The Pirbright Institute.

Go to main content

Filters

Filters

Enter keywords

Select virus

Select month

Select researcher

Featured news

Artist impression of CVIM building

CVIM and Tiba Biotech join forces to advance RNA-based livestock vaccines

A collaboration to accelerate the development of next-generation RNA vaccines targeting high-impact livestock diseases has been forged between the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) and biopharmaceutical company Tiba Biotech. Supported by funding from the Gates…

Close up of two pink pigs lying on straw

Pigs ‘human-like’ antibody responses to flu can aid advancement of novel therapeutics

Research led by scientists at The Pirbright Institute has highlighted the role played by pigs as a key natural host and important preclinical model for influenza. The study, published today in Discovery Immunology, shows that pigs can generate antibody responses similar to those seen in humans…

Latest news

pig lying in hay pirbright

Pirbright scientists help combat African swine fever - a disease with no vaccine

African swine fever (ASF) continues to spread throughout eastern and central Europe, and China has now recorded its first outbreak. China is home to over half the world’s pig population (around 500 million pigs) so any potential spread throughout China and neighbouring countries would be devastating…

Cells infected with African swine fever

23 February 2018

Advance in the hunt for African swine fever vaccine

Researchers from The Pirbright Institute have made a promising step forward by identifying key African swine fever virus (ASFV) proteins that induce immune responses in pigs. ASFV is an extremely severe and economically important disease of domestic pigs, which is usually fatal in pigs and wild boar…

African swine fever advance through Europe

The continued advance of African swine fever (ASF) through Eastern European countries has triggered concern amongst pig farmers and governing bodies. Defra has upgraded the threat to the UK from ‘very low’ to ‘low’ – meaning the risk is “rare but could occur” (EFSA terminology). This severe disease…